. Author manuscript; available in PMC: 2015 Apr 1.

Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2014 Jan 22;14(2):163–171. doi: 10.1016/j.clml.2013.07.009

Table 1. Induction treatment regimens.

Treatment regimen	No. of patients (%) 483
High dose cytarabine based regimens	340 (70)
Idarubicin/cytarabine	151 (44)
Daunorubicin/cytarabine	26 (9)
Cyclophosphamide/cytarabine/topotecan	45 (13)
Fludarabine/cytarabine +/- idarubicin	45 (13)
Clofarabine/cytarabine	16 (5)
Topotecan/cytarabine	14 (4)
Miscellaneous high dose cytarabine based regimens	43 (12)
Other regimens	143 (30)
Hypomethelating agents +/- other drugs	44 (31)
Clofarabine based regimens	35 (24)
Gemtuzumab ozogamicin + interleukin 11	21 (15)
Miscellaneous	43 (30)